Skip to main content
KYMR
NASDAQ Life Sciences

Kymera's KT-485 Enters Phase 1 Trial, Triggers $20M Sanofi Milestone with $975M Potential

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$73.95
Mkt Cap
$6.083B
52W Low
$36.65
52W High
$103
52W Position info
102% above low
Off High info
28% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

KYMR has more than doubled off its 52-week low of $36.65.

Summary

Kymera Therapeutics announced the dosing of the first participant in its Phase 1 trial for KT-485, an oral IRAK4 degrader. This significant pipeline advancement triggered a $20 million milestone payment from Sanofi, with the potential for up to $975 million in additional milestones. This follows recent positive news including strong Q1 results and promising preclinical data for other candidates. Advancing KT-485 into human trials is a key de-risking event for the program and provides substantial non-dilutive capital, validating the Sanofi collaboration. Future updates on the Phase 1 trial will be important.

At the time of this announcement, KYMR was trading at $73.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $36.65 to $103.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

KYMR - Latest Insights

KYMR
Oct 29, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $122.01
Real-time Price: $128.67 info
Change: +$6.66 (+5%) info
Market Cap: $11.632B info
KYMR
Oct 29, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $122.01
Real-time Price: $128.67 info
Change: +$6.66 (+5%) info
Market Cap: $11.632B info
KYMR
Aug 06, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $105.48
Real-time Price: $128.67 info
Change: +$23.19 (+22%) info
Market Cap: $11.632B info
KYMR
Aug 05, 2026, 7:15 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $104.52
Real-time Price: $128.67 info
Change: +$24.15 (+23%) info
Market Cap: $11.632B info
KYMR
Aug 05, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $104.52
Real-time Price: $128.67 info
Change: +$24.15 (+23%) info
Market Cap: $11.632B info